Drug-induced liver injury: past, present and future. - Wikidata - awgldk - TriplyDB

Drug-induced liver injury: past, present and future.

Drug-induced liver injury: past, present and future.

http://www.wikidata.org/entity/Q37736444

about

Drug-induced liver injury: present and future MicroRNAs in Drug-induced Liver Injury Perspectives on systems biology applications in diabetic kidney disease Drug allergy: causes and desensitization Metabolomics and diabetes: analytical and computational approaches Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients Fatal case of sorafenib-associated idiosyncratic hepatotoxicity in the adjuvant treatment of a patient with renal cell carcinoma A genome-wide association study of metabolic traits in human urine.Evaluation of patterns of liver toxicity in patients on antiretroviral and anti-tuberculosis drugs: a prospective four arm observational study in ethiopian patients.Databases in the area of pharmacogenetics.Oral clindamycin causing acute cholestatic hepatitis without ductopenia: a brief review of idiosyncratic drug-induced liver injury and a case report Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview.Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here?Molecular mechanisms underlying chemical liver injury.Role of polymorphic bile salt export pump (BSEP, ABCB11) transporters in anti-tuberculosis drug-induced liver injury in a Chinese cohort.Assessment of a pharmacogenomic marker panel in a polypharmacy population identified from electronic medical records HLA-B*57 Allele Is Associated with Concomitant Anti-tuberculosis and Antiretroviral Drugs Induced Liver Toxicity in Ethiopians.Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis.Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity.My child is unique; the pharmacokinetics are universal.The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury.A prospective nationwide study of drug-induced liver injury in Korea.Latest advances in predicting DILI in human subjects: focus on biomarkers.Antibiotic induced liver injury: what about children?Contributions of pharmacogenetics and transcriptomics to the understanding of the hypersensitivity drug reactions.Application of urine proteomics for biomarker discovery in drug-induced liver injury.The chemical, genetic and immunological basis of idiosyncratic drug-induced liver injury.Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.Genome-Wide Association Studies for Idiosyncratic Drug-Induced Hepatotoxicity: Looking Back-Looking Forward to Next-Generation Innovation.Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.PharmGKB summary: isoniazid pathway, pharmacokinetics.A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.Polymorphisms of glutathione S-transferase mu 1, theta 1, and pi 1 genes and prognosis in Hodgkin lymphoma.The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers.Safe and effective medicines for all: is personalized medicine the answer?The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacapone.Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case-Control Study.Drug-Induced Liver Injury: An Institutional Case Series and Review of Literature.

P2860

Q24630227-D2AC74CF-471B-4A77-B6EB-97E838C6F30A Q26781801-3EE2763A-1D0F-4BEE-B70E-AB78953D059D Q26823206-7984D017-6E4B-422A-B93A-4CCEE595F09F Q27012238-AA4703B9-1AB2-4F8A-9DBE-A6876A5F93D6 Q28084835-92AA1DE2-557D-4DEC-9F20-F420308F8AAE Q28478275-2B49D62D-A35F-4FB4-91B0-C39442C9273E Q31108636-5246085A-731A-4F91-871C-1CC6CD03B8B1 Q34185066-8B26A385-2BD9-4BDD-B734-99844AAB2F2F Q35142786-671B628B-7681-4DC1-9DCC-2D213A594D7C Q35959328-5814E99B-4162-49D5-8515-E0A38DD697AD Q36182393-385E938E-480B-4D3A-BCBD-1FB6F01A2DC8 Q36490242-224BCDCC-D306-4C12-A1DB-12DB152C93E4 Q36796350-5E4D9E83-F83D-44BC-8902-567EAA1A05CA Q36811351-DD81C043-C900-4D3A-BB10-DC1A986CB739 Q36991523-AD68D3CB-12C8-4C3A-8CE3-88AFAD5EF0A4 Q36996132-63FA306C-0A75-41C8-9AF4-429E614608E9 Q37051236-9FB6ACF1-A6DC-479D-A13C-1C133FA8F9B3 Q37667333-939928E8-FD9E-471D-9E17-F1126916B000 Q37841614-86816D97-9FD3-4EBF-BD2D-2C004C8FDD4A Q37862739-33E8C794-0981-42B1-B0B1-C2D327714A77 Q37973872-E370DCD5-ED89-4ECF-BF32-EA1756A167D1 Q37979858-E3731008-BD26-4B61-9A2E-3CE43796F837 Q38021681-2CCC8AF5-1940-4494-A6F9-39F87461F4A7 Q38045377-80617E4C-D4C2-4428-98FD-2033B1175004 Q38144140-3AD0197B-A95E-411E-8504-D6748DF20087 Q38182188-D0911819-1E98-4673-9C22-B5C16032BF9A Q38255178-09108E83-0175-4D05-9B70-5FB19358E6B2 Q38651282-5D808C35-A00B-4B33-A313-4EC3E8029039 Q38733565-1277CC31-F982-4CDD-98DD-73804C005786 Q39158128-D536F6A0-0BB6-4987-97CF-9202222D7291 Q40454552-0DA71260-5BAA-4480-8F4A-3C3E7586BA74 Q42090708-33F7546B-284F-49FA-A259-5CC6A2ECE901 Q42709815-A73F4CA6-AF83-4E96-8580-E90BFEF6BA57 Q42846956-03ACF2A3-2880-46EB-8C86-A09FDDA80DE5 Q43137450-5744EC9C-E8AE-492B-8820-057604509D7F Q44483899-28F317E7-FFAD-4D75-928F-B8EEC546537D Q44650640-5D8B0068-08EA-4E36-B4D4-70ACE299DFAF Q50124934-4CC9ECB1-0827-40E3-8DDF-2A4603D7EF56 Q55345230-E05E2E32-AF8D-4ACE-AA9D-A7BF9E913793

P2860

Drug-induced liver injury: past, present and future.

http://www.wikidata.org/entity/Q37736444

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Drug-induced liver injury: past, present and future.

@en

Drug-induced liver injury: past, present and future.

@nl

type

label

Drug-induced liver injury: past, present and future.

@en

Drug-induced liver injury: past, present and future.

@nl

prefLabel

Drug-induced liver injury: past, present and future.

@en

Drug-induced liver injury: past, present and future.

@nl

P1433

Q37736444-60320F4B-D63B-49F2-AB3E-3F4119A77936

P1476

Q37736444-BF58F669-117A-4329-AF2C-85F7C7EFAAC5

P2093

Q37736444-3DE16968-554A-4D57-8F11-DEED156CEDC6

P2860

Q37736444-02A0E0EF-D5EC-461E-A530-97CC2AE0B54B

Q37736444-076A6C32-6773-4D2B-8E7C-46ED83CE86D8

Q37736444-2313C356-12A8-40EA-8D4A-D32EFF5DD989

Q37736444-23CE6B8F-F78F-4A0D-8A1C-66FA0BF24C89

Q37736444-3012553C-E108-4BD3-8C99-172FAFA5F44E

Q37736444-371CC57E-ADA7-4E93-934F-E55977C9999C

Q37736444-3F79117F-983C-4DF4-B553-D4FDC9CDD594

Q37736444-46A32FC1-64EC-4570-8DC9-94FF87B8F5D6

Q37736444-4A534097-A4CC-4833-85B5-084C1DCFBAFE

Q37736444-711CBF00-C315-41BD-AE63-B0F5D28E4541

P304

Q37736444-B17305D5-4472-49C5-8931-3B8156208B66

P31

Q37736444-838843E1-9CC7-45AE-AC47-84A8EE4665AE

P356

Q37736444-B11CB454-E6EB-4F5B-BEB0-B25863ECC006

P433

Q37736444-BBE39B3D-C7BC-4308-9A58-3952C8ED82ED

P478

Q37736444-AB758618-D8F8-4778-B1AB-84B136089E8A

P50

Q37736444-3C82CB8B-8A71-4397-8C94-1699AC4E50DC

P577

Q37736444-3E67D1BB-E4B6-46E7-89E1-D4F96F78BD77

P5875

Q37736444-F8FD1937-CBF0-4064-B67D-6C050199F8D6

P698

Q37736444-EC56DC4C-F84D-4DC0-A952-E7006749938C

P356

P1433

Pharmacogenomics

P1476

Drug-induced liver injury: past, present and future

@en

P2093

Ann K Daly

http://www.w3.org/2001/XMLSchema#string

P2860

HLA association of amoxicillin-clavulanate--induced hepatitis

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.

Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases.

CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.

Molecular and genetic association of interleukin-6 in tacrine-induced hepatotoxicity.

Co-amoxiclav jaundice: clinical and histological features and HLA class II association.

Idiosyncratic drug hepatotoxicity.

MRP2 haplotypes confer differential susceptibility to toxic liver injury.

Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation.

P304

607-611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.10.24

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43340101

http://www.w3.org/2001/XMLSchema#string

P698

20415545

http://www.w3.org/2001/XMLSchema#string